New combo therapy aims to boost survival in kids with aggressive lymphoma
NCT ID NCT02405676
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding four doses of rituximab to an intensified chemotherapy regimen improves outcomes for children and teens with advanced B-cell non-Hodgkin lymphoma or B-cell acute leukemia. About 200 participants in China will receive the new treatment, and researchers will compare their event-free survival to a previous study. The goal is to find a more effective way to control these aggressive cancers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Rituximab (a targeted antibody) plus chemotherapy drugs (prednisone, vincristine, cyclophosphamide, cytarabine, doxorubicin, ifosfamide, etoposide, methotrexate)
- What this could lead to
- If successful, this could lead to a more effective treatment regimen for children with advanced B-cell lymphoma or leukemia, improving their chances of staying cancer-free.
- What could go wrong
- This is a Phase 2/3 trial, so results are not yet confirmed. The stronger chemotherapy may cause more side effects, and the benefit of adding rituximab is still being tested.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGGRESSIVE MATURE B-CELL NON-HODGKIN LYMPHOMA NOT OTHERWISE SPECIFIED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
West China Second University Hospital of Sichuan University
Chengdu, Sichuan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells plus a checkpoint drug outsmart lymphoma?
- Can an immune booster outsmart brain lymphoma?
- A shot at safer CAR t: early brain protection for lymphoma patients?
- Engineered immune cells take aim at Hard-to-Treat lymphomas
- Can donor immune cells be engineered to fight blood cancer?
- Can a simple blood test spot lymphoma earlier?